FDA Inspection 1123192 — Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals Corporation — FEI 3011197697

The FDA completed an inspection of Biotest Pharmaceuticals Corporation on February 28, 2020 in Marietta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Marietta, GA (United States)